Cargando…

Prevalence and Risk Factors of Hyperuricemia and Gout: A Cross-sectional Survey from 31 Provinces in Mainland China

BACKGROUND AND OBJETIVES: Hyperuricemia (HUA) and gout seriously influence patients’ quality of life. The current study was performed to investigate the prevalence of HUA and gout and the related risk factors in Chinese adults. METHODS: Data were collected from the National Survey of Thyroid Disorde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Jing, Jin, Chenye, Shan, Zhongyan, Teng, Weiping, Li, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328039/ https://www.ncbi.nlm.nih.gov/pubmed/35959454 http://dx.doi.org/10.2478/jtim-2022-0031

Ejemplares similares

Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis
por: Liu, Rui, et al.
Publicado: (2015)

Prevalence and risk factors of hypothyroidism after universal salt iodisation: a large cross-sectional study from 31 provinces of China
por: Li, Jiashu, et al.
Publicado: (2023)

Effect of the transition from more than adequate iodine to adequate iodine on national changes in the prevalence of thyroid disorders: repeat national cross-sectional surveys in China
por: Li, Yongze, et al.
Publicado: (2021)

Changes in the prevalence of obesity and hypertension and demographic risk factor profiles in China over 10 years: two national cross-sectional surveys
por: Li, Yongze, et al.
Publicado: (2021)

Gout. Novel therapies for treatment of gout and hyperuricemia
por: Terkeltaub, Robert
Publicado: (2009)

Prevalence of burnout among intensivists in mainland China: a nationwide cross-sectional survey
por: Wang, Jing, et al.
Publicado: (2021)

Susceptibility genes of hyperuricemia and gout
por: Nian, Yue-Li, et al.
Publicado: (2022)

Prevalence of Diabetic Retinopathy in Mainland China: A Meta-Analysis
por: Liu, Lei, et al.
Publicado: (2012)

Prevalence of Goiter and Thyroid Nodules before and after Implementation of the Universal Salt Iodization Program in Mainland China from 1985 to 2014: A Systematic Review and Meta-Analysis
por: Zhao, Wei, et al.
Publicado: (2014)

Associations of metal exposure with hyperuricemia and gout in general adults
por: Xu, Jing, et al.
Publicado: (2022)

Management of hyperuricemia in gout: focus on febuxostat
por: Reinders, Mattheus K, et al.
Publicado: (2010)

An update on the genetic architecture of hyperuricemia and gout
por: Merriman, Tony R
Publicado: (2015)

Pharmacological effects of Chatuphalatika in hyperuricemia of gout
por: Sato, Vilasinee Hirunpanich, et al.
Publicado: (2018)

The role of the Mediterranean diet in hyperuricemia and gout
por: Stamostergiou, Julie, et al.
Publicado: (2018)

The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: a cross-sectional study
por: Liang, Jing, et al.
Publicado: (2020)

Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study
por: Li, Yongze, et al.
Publicado: (2020)

Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
por: Ito, Shuichi, et al.
Publicado: (2020)

Gout, not hyperuricemia alone, impairs left ventricular diastolic function
por: Lin, Jing-Chi, et al.
Publicado: (2015)

A concise history of gout and hyperuricemia and their treatment
por: Nuki, George, et al.
Publicado: (2006)

Atypical musculoskeletal manifestations of gout in hyperuricemia patients
por: Sakti, Muhammad, et al.
Publicado: (2019)

Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout
por: Pérez-Ruiz, Fernando, et al.
Publicado: (2019)

Performance of Ultrasound in the Clinical Evaluation of Gout and Hyperuricemia
por: Cao, Ling, et al.
Publicado: (2021)

Why Does Hyperuricemia Not Necessarily Induce Gout?
por: Zhang, Wei-Zheng
Publicado: (2021)

The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics
por: Wu, Xinghong, et al.
Publicado: (2023)

The prevalence of gout and hyperuricemia in middle-aged and elderly people in Tibet Autonomous Region, China: A preliminary study
por: Zhang, Qingxi, et al.
Publicado: (2020)

Geographical distribution of hyperuricemia in mainland China: a comprehensive systematic review and meta-analysis
por: Huang, Jiayun, et al.
Publicado: (2020)

Medical Students’ Perspective and Knowledge of Asymptomatic Hyperuricemia and Gout Management: A Cross-Sectional Study
por: Zuzic Furlan, Sanja, et al.
Publicado: (2021)

The prevalence of hyperuricemia and its correlates in Ganzi Tibetan Autonomous Prefecture, Sichuan Province, China
por: Zhang, Xin, et al.
Publicado: (2018)

Prevalence and Risk Factors Associated with Hyperuricemia in the Pearl River Delta, Guangdong Province, China
por: Liu, Weiqi, et al.
Publicado: (2021)

Febuxostat in the management of hyperuricemia and chronic gout: a review
por: Hu, Miao, et al.
Publicado: (2008)

Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout
por: Gaffo, Angelo L, et al.
Publicado: (2010)

Febuxostat: A Novel Agent for Management of Hyperuricemia in Gout
por: Bisht, Manisha, et al.
Publicado: (2011)

Circulating microRNA alternations in primary hyperuricemia and gout
por: Bohatá, Jana, et al.
Publicado: (2021)

Treatment for hyperuricemia and gout in Japan: Aspect of prescription and duration
por: Zhang, Di
Publicado: (2022)

Epidemiology and treatment-related concerns of gout and hyperuricemia in Korean
por: Ahn, Joong Kyong
Publicado: (2023)

Estimated change in prevalence of abnormal thyroid-stimulating hormone levels in China according to the application of the kit-recommended or NACB standard reference interval
por: Li, Yongze, et al.
Publicado: (2021)

The prevalence of thalassemia in mainland China: evidence from epidemiological surveys
por: Lai, Ketong, et al.
Publicado: (2017)

Trends in the Epidemiology of Sexually Transmitted Disease, Acquired Immune Deficiency Syndrome (AIDS), Gonorrhea, and Syphilis, in the 31 Provinces of Mainland China
por: Ye, Xuechen, et al.
Publicado: (2019)

Disease burden of ageing, sex and regional disparities and health resources allocation: a longitudinal analysis of 31 provinces in Mainland China
por: Chen, Shu, et al.
Publicado: (2022)

Advances in the management of gout: Critical appraisal of febuxostat in the control of hyperuricemia
por: Beara-Lasic, Lada, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_huvcpp4h0pe6s1r7rube3nuk4r